“…Progressive sensorineural hearing loss has been described as part of the clinical presentation in several genetic forms of CMT, including various mutations in the MPZ gene [Chapon et al, 1999;De Jonghe et al, 1999;Alcin et al, 2000;Misu et al, 2000;Starr et al, 2003;Kochanski et al, 2004;Seeman et al, 2004;Leal et al, 2014;Tokuda et al, 2015;Duan et al, 2016], in kinships demonstrating mutations in the peripheral myelin protein (PMP22) gene [Alcin et al, 2000;Boerkoel et al, 2002;Kovach et al, 2002;Joo et al, 2004], in X-linked phosphoribosyl pyrophosphate synthetase-1 (PRPS-1) mutations [Synofzik et al, 2014;Gandia et al, 2015], and in CMT4C [Sivera et al, 2017].…”